William Benton Jones - Dec 20, 2022 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
Stock symbol
CRVS
Transactions as of
Dec 20, 2022
Transactions value $
$15,800
Form type
4
Date filed
12/20/2022, 05:22 PM
Previous filing
Aug 15, 2022
Next filing
Dec 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $15.8K +20K +17.58% $0.79 134K Dec 20, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

SVP, Pharmaceutical Development